Instil Bio (TIL) Financials: Revenue & Earnings
$46.73M
Market Cap
—
P/E
—
Forward P/E
—
Score
TIL price $6.89 +0.10 +1.47%
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Instil Bio, Inc. (TIL) trades at $6.89, with a market cap of $46.73M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$46.73M
Market Cap
—
P/E
—
Forward P/E
—
Score